Skip to main content

4 July 2025

Last updated: Tuesday 1 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Why pharma is paying a premium for assets

Sunday 18 March 2018

Interviewee/Contributor

Tim Sturgeon and Martin Gouldstone

Organisation

Results Healthcare

The Trump impact on healthcare M&A

Monday 24 April 2017

Interviewee/Contributor

Tim Sturgeon

Organisation

Results Healthcare

Organisations

MIT Technology Licensing Office
Skin2Neuron Pty Ltd
Auspherix Ltd
OxStem Ltd
Rinri Therapeutics Ltd
Kilburn & Strode
Immunocore Ltd
Allero Therapeutics BV
Transimmune AG
Morgan Prestwich Executive Search

Interviewees and Contributers

John Ridley
Maarten Meulenbelt
Sean Morgan-Jones
Mark Throsby
Alain Vertès
Niall Martin and Jonathan Tobin
Victoria English and Jean-Claude Muller
Carlos Buesa
Genghis Lloyd-Harris
Marisa Papaluca-Amati

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form